abstract |
The present invention relates to controlling blood glucose levels in an animal comprising consumption of the composition comprising beta-casein or providing the composition to the animal for consumption, wherein the beta-casein comprises at least 75% Beta-casein A2. ≪ / RTI > The present invention includes uses for addressing the symptoms of hyperglycemia and related disorders, including diabetes. The effect is both acute (after exposure to the composition) and progression. |